Dayspring Pharma is a China-based clinical-stage pharmaceutical company developing differentiated small molecules and formulations across oncology, cardiovascular disease, and CNS — with GMP-certified manufacturing capabilities.
We welcome discussions with global pharma and biotech companies seeking clinical-stage assets with manufacturing readiness in high-unmet-need indications.
✉ Contact our BD TeamA clinical-stage pharmaceutical company advancing differentiated therapeutics from discovery through GMP manufacturing to global partnership.
Three programs spanning from Phase II to IND-ready, across oncology, cardiovascular, and CNS indications.
| Name / Mechanism | Indication | Development Stage |
|---|
Peer-reviewed publications, conference presentations and clinical trial registrations underpinning our pipeline.
Whether you're exploring licensing opportunities, have scientific questions, or wish to connect for any other purpose — we'd be glad to hear from you.
Our Business Development team actively engages with global pharmaceutical and biotech companies on licensing, co-development, and out-partnering discussions. We welcome your inquiry and aim to respond within two business days.
How Dayspring Pharma handles website information, business enquiry data, and communications submitted through this site.
The conditions governing access to and use of this website and its corporate content.
A quick guide to the main sections of the Dayspring Pharma website.